Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Saccharomyces cerevisiae | 6 | 2018 | 199 | 1.410 |
Why?
|
| Saccharomyces cerevisiae Proteins | 9 | 2020 | 110 | 1.090 |
Why?
|
| DNA Repair | 6 | 2024 | 198 | 0.830 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2018 | 51 | 0.820 |
Why?
|
| Doxorubicin | 2 | 2018 | 97 | 0.790 |
Why?
|
| Allyl Compounds | 4 | 2024 | 55 | 0.680 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2020 | 4 | 0.640 |
Why?
|
| DNA-Binding Proteins | 7 | 2009 | 561 | 0.640 |
Why?
|
| Cytotoxins | 1 | 2020 | 11 | 0.640 |
Why?
|
| Aldehydes | 1 | 2018 | 70 | 0.550 |
Why?
|
| Garlic | 3 | 2024 | 31 | 0.440 |
Why?
|
| MutS Homolog 2 Protein | 4 | 2009 | 32 | 0.420 |
Why?
|
| Sulfides | 3 | 2024 | 78 | 0.420 |
Why?
|
| Precancerous Conditions | 2 | 2024 | 83 | 0.390 |
Why?
|
| Manganese | 1 | 2013 | 92 | 0.380 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 1019 | 0.350 |
Why?
|
| Adenosine Triphosphatases | 6 | 2009 | 83 | 0.340 |
Why?
|
| Meiosis | 2 | 2009 | 67 | 0.340 |
Why?
|
| DNA Replication | 5 | 2000 | 148 | 0.340 |
Why?
|
| HMGN Proteins | 1 | 2009 | 1 | 0.320 |
Why?
|
| Base Pair Mismatch | 4 | 2009 | 15 | 0.320 |
Why?
|
| DNA Repair Enzymes | 1 | 2009 | 22 | 0.310 |
Why?
|
| DNA Mismatch Repair | 1 | 2009 | 28 | 0.300 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 306 | 0.280 |
Why?
|
| Testis | 1 | 2009 | 207 | 0.280 |
Why?
|
| Genome, Fungal | 1 | 2007 | 28 | 0.270 |
Why?
|
| Carrier Proteins | 1 | 2009 | 321 | 0.260 |
Why?
|
| Proliferating Cell Nuclear Antigen | 5 | 2002 | 47 | 0.260 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 1723 | 0.240 |
Why?
|
| Anticarcinogenic Agents | 2 | 2024 | 77 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 532 | 0.230 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2025 | 67 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 307 | 0.220 |
Why?
|
| Cadmium | 1 | 2005 | 56 | 0.220 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 512 | 0.210 |
Why?
|
| Antifungal Agents | 2 | 2016 | 169 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 218 | 0.190 |
Why?
|
| Gene Silencing | 2 | 2017 | 154 | 0.190 |
Why?
|
| Epithelial Cells | 2 | 2024 | 434 | 0.180 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2021 | 40 | 0.170 |
Why?
|
| Neoplasms | 2 | 2023 | 1377 | 0.170 |
Why?
|
| Cell Survival | 3 | 2020 | 945 | 0.170 |
Why?
|
| Fungal Proteins | 2 | 2002 | 142 | 0.170 |
Why?
|
| Phenotype | 4 | 2013 | 780 | 0.170 |
Why?
|
| Humans | 19 | 2025 | 43102 | 0.170 |
Why?
|
| Language | 1 | 2022 | 185 | 0.160 |
Why?
|
| Breast | 1 | 2021 | 139 | 0.160 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2020 | 51 | 0.160 |
Why?
|
| Antioxidants | 3 | 2024 | 443 | 0.160 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 95 | 0.160 |
Why?
|
| Adenosine Triphosphate | 3 | 2017 | 206 | 0.160 |
Why?
|
| DNA | 3 | 2024 | 592 | 0.150 |
Why?
|
| Genome | 1 | 2000 | 149 | 0.150 |
Why?
|
| Frameshift Mutation | 1 | 1998 | 9 | 0.150 |
Why?
|
| Genes, Fungal | 1 | 1998 | 33 | 0.150 |
Why?
|
| Cyclins | 2 | 1995 | 34 | 0.140 |
Why?
|
| RNA Nucleotidyltransferases | 2 | 1996 | 2 | 0.130 |
Why?
|
| Fungi | 2 | 2016 | 106 | 0.130 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 64 | 0.130 |
Why?
|
| DNA, Fungal | 3 | 2002 | 49 | 0.130 |
Why?
|
| Protein Binding | 4 | 2009 | 1082 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2017 | 112 | 0.120 |
Why?
|
| Mutation | 3 | 2013 | 1177 | 0.120 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 11 | 0.120 |
Why?
|
| Benzoquinones | 1 | 2015 | 47 | 0.110 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1994 | 4 | 0.110 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1994 | 26 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 436 | 0.110 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1994 | 23 | 0.110 |
Why?
|
| Disulfides | 1 | 2015 | 95 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 95 | 0.110 |
Why?
|
| Quinolinium Compounds | 1 | 2013 | 9 | 0.100 |
Why?
|
| DNA Damage | 3 | 2024 | 356 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 196 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 187 | 0.100 |
Why?
|
| Magnesium | 1 | 2013 | 94 | 0.100 |
Why?
|
| Microglia | 1 | 2015 | 208 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 384 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 968 | 0.100 |
Why?
|
| Alleles | 1 | 2013 | 352 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 333 | 0.090 |
Why?
|
| Biological Products | 1 | 2013 | 91 | 0.090 |
Why?
|
| Cell Cycle | 3 | 2021 | 346 | 0.090 |
Why?
|
| Benzo(a)pyrene | 2 | 2024 | 128 | 0.090 |
Why?
|
| Cell Nucleus | 1 | 1993 | 383 | 0.090 |
Why?
|
| Female | 6 | 2024 | 24698 | 0.090 |
Why?
|
| Animals | 6 | 2025 | 16992 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 432 | 0.080 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2009 | 19 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 183 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 56 | 0.070 |
Why?
|
| Mice | 3 | 2025 | 6644 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2009 | 183 | 0.070 |
Why?
|
| Genetic Complementation Test | 1 | 2007 | 56 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 1 | 2007 | 27 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2007 | 36 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 2676 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2000 | 1542 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 228 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 223 | 0.060 |
Why?
|
| Base Sequence | 3 | 2001 | 983 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2007 | 149 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 1996 | 152 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2025 | 39 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 1996 | 150 | 0.060 |
Why?
|
| Sulfhydryl Reagents | 1 | 2005 | 6 | 0.060 |
Why?
|
| Ethylmaleimide | 1 | 2005 | 8 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 19 | 0.060 |
Why?
|
| Amino Acids | 1 | 2005 | 148 | 0.050 |
Why?
|
| Zinc | 1 | 2005 | 131 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2016 | 245 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2002 | 186 | 0.050 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2024 | 52 | 0.050 |
Why?
|
| Repressor Proteins | 2 | 1996 | 273 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 2000 | 92 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2000 | 1180 | 0.050 |
Why?
|
| Universities | 1 | 2025 | 559 | 0.050 |
Why?
|
| DNA Polymerase beta | 1 | 2021 | 14 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 2021 | 25 | 0.040 |
Why?
|
| Hela Cells | 4 | 1996 | 376 | 0.040 |
Why?
|
| Crossing Over, Genetic | 1 | 2001 | 6 | 0.040 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2001 | 9 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1124 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 284 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 2000 | 21 | 0.040 |
Why?
|
| Florida | 1 | 2023 | 478 | 0.040 |
Why?
|
| California | 1 | 2023 | 548 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2025 | 502 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2000 | 267 | 0.040 |
Why?
|
| Eukaryotic Cells | 1 | 2000 | 35 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 272 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1271 | 0.040 |
Why?
|
| Binding Sites | 1 | 2000 | 671 | 0.040 |
Why?
|
| Simian virus 40 | 2 | 1995 | 35 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1995 | 56 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2024 | 1003 | 0.030 |
Why?
|
| RNA Helicases | 2 | 1996 | 19 | 0.030 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 71 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 168 | 0.030 |
Why?
|
| Stomach Diseases | 1 | 1996 | 5 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 1996 | 11 | 0.030 |
Why?
|
| Male | 2 | 2022 | 23409 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 2016 | 10 | 0.030 |
Why?
|
| Apoptosis | 1 | 2024 | 1568 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 1996 | 65 | 0.030 |
Why?
|
| Mycoses | 1 | 2016 | 31 | 0.030 |
Why?
|
| Autoantigens | 1 | 1996 | 87 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 455 | 0.030 |
Why?
|
| Anthracenes | 1 | 2015 | 15 | 0.030 |
Why?
|
| Butadienes | 1 | 2015 | 29 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 32 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 21 | 0.030 |
Why?
|
| Nitrites | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 95 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 244 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1455 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 456 | 0.030 |
Why?
|
| Nitriles | 1 | 2015 | 81 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 105 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 1994 | 5 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 119 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2015 | 128 | 0.030 |
Why?
|
| DNA Polymerase III | 1 | 1994 | 9 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1994 | 15 | 0.030 |
Why?
|
| Imidazoles | 1 | 2015 | 142 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1994 | 32 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 139 | 0.030 |
Why?
|
| Magnesium Chloride | 1 | 1993 | 2 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 458 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 239 | 0.030 |
Why?
|
| RNA Splicing | 1 | 1993 | 41 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3156 | 0.030 |
Why?
|
| Vero Cells | 1 | 2013 | 112 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 197 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 458 | 0.020 |
Why?
|
| Biological Transport | 1 | 1993 | 204 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1993 | 154 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 986 | 0.020 |
Why?
|
| Virus Replication | 1 | 1994 | 318 | 0.020 |
Why?
|
| Drug Design | 1 | 2013 | 186 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 506 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 570 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 678 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 529 | 0.020 |
Why?
|
| Bacteria | 1 | 2013 | 293 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1070 | 0.020 |
Why?
|
| DNA Primers | 2 | 2001 | 294 | 0.020 |
Why?
|
| Replication Protein C | 2 | 1996 | 3 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 1996 | 10 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 1996 | 196 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 13872 | 0.010 |
Why?
|
| Kinetics | 2 | 1996 | 695 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 97 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 135 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 462 | 0.010 |
Why?
|
| Baculoviridae | 1 | 1996 | 12 | 0.010 |
Why?
|
| Spodoptera | 1 | 1996 | 16 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1996 | 23 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1996 | 52 | 0.010 |
Why?
|
| Sequence Tagged Sites | 1 | 1995 | 4 | 0.010 |
Why?
|
| Histidine | 1 | 1995 | 43 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1995 | 27 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 132 | 0.010 |
Why?
|
| Transfection | 1 | 1996 | 532 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 314 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 518 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1995 | 118 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1996 | 117 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1995 | 307 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 592 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 1410 | 0.010 |
Why?
|
| Peptides | 1 | 1995 | 372 | 0.010 |
Why?
|